Adimab, LLC

CIK 1545672 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adimab, LLC.

Recent SEC filings

FiledFormAccession number
Dec 29, 2025SCHEDULE 13D/A0001193125-25-335350
Dec 23, 20251440001950047-25-010678
Nov 19, 2025SCHEDULE 13D/A0001193125-25-288171
Nov 17, 20251440001950047-25-008974
Jan 22, 202440000950170-24-006070
Jan 22, 2024SC 13D/A0001193125-24-012170
Jan 19, 20241440001950047-24-000381
Jun 24, 2022SC 13D/A0001193125-22-181609
Apr 26, 2022SC 13D/A0001193125-22-118250
Apr 1, 202240000899243-22-013098
Mar 30, 2022SC 13D0001193125-22-089834
Aug 12, 202140001209191-21-051295
Aug 5, 202130001209191-21-050066
Apr 2, 2012D0001545672-12-000001